Pharmaceutical compositions comprising 2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione… Grant US-11786486-B2 United States of America 17 Oct 2023
2,3,5-TRIMETHYL-6-NONYLCYCLOHEXA-2,5-DIENE-1,4-DIONE FOR SUPPRESSING AND TREATING ALPHA-SYN… Grant EP-3866772-B1 European Patent Office 11 Oct 2023
2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-syn… Grant US-11746077-B2 United States of America 05 Sep 2023
2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-syn… Grant US-11667596-B2 United States of America 06 Jun 2023
Compositions for modulating C9ORF72 expression Grant US-11339393-B2 United States of America 24 May 2022
Compounds and methods for modulating C90RF72 Grant US-11260073-B2 United States of America 01 Mar 2022
Compositions for modulating C9ORF72 expression Grant US-10443052-B2 United States of America 15 Oct 2019
Compositions for modulating C9ORF72 expression Grant US-10221414-B2 United States of America 05 Mar 2019
Compositions for modulating C9ORF72 expression Grant US-9605263-B2 United States of America 28 Mar 2017